Cancer-associated carbohydrates identified by monoclonal antibodies.
about
Characterizing glycosylation pathwaysRegulation of the metastatic cell phenotype by sialylated glycansGlycotherapy: new advances inspire a reemergence of glycans in medicineA Sialyltransferase Mutant with Decreased Donor Hydrolysis and Reduced Sialidase Activities for Directly Sialylating Lewis xDevelopment and Applications of the Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) as a Bioorthogonal ReactionA mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data.Metabolic labeling of sialic acids in living animals with alkynyl sugars.Comparison of two sialosyl-Tn binding monoclonal antibodies (MLS102 and B72.3) in detecting pancreatic cancer.Integration of the transcriptome and glycome for identification of glycan cell signatures.Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probesAlkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.A tumour-associated cell-surface glycoprotein accompanying p53 overexpression and higher growth potential for gastric cancer.A systematic framework to derive N-glycan biosynthesis process and the automated construction of glycosylation networks.Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis.Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycansSpecificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21.Chemical probing of glycans in cells and organismsClinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis.State of the art in tumor antigen and biomarker discovery.Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomasSpecificity in cancer immunotherapy.Carbohydrate vaccines: developing sweet solutions to sticky situations?Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.Development of fucosyltransferase and fucosidase inhibitors.Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.Improving vaccine efficacy against malignant gliomaHarnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.Thomsen-Friedenreich oncofetal antigen in Schistosoma mansoni : localization and immunogenicity in experimental mouse infection.Metabolic selection of glycosylation defects in human cells.Mucus glycoproteins and their role in colorectal disease.Concepts of tumor lectinology.Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells.Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma.Lectin histochemistry of laryngeal squamous cell carcinomas.Protective Effect of Allyl Isothiocyanate on Glycoprotein Components in 7,12-dimethylbenz(a)anthracene Induced Mammary Carcinoma in Rats.
P2860
Q24805500-AE3F6A2D-CCD5-4100-9FE6-5953C99B762EQ27027559-3B39D2BB-9BA3-4201-904E-A2093613CB37Q27027997-FBCD411A-3CEC-4A6F-A867-BAD7919730BDQ27679080-07165550-1E51-4CF2-9C74-8118D53ED6CCQ28079295-03E4C236-1296-4979-B743-0DB745F9991FQ33464097-88B0DD0E-941D-448F-8C74-B126558CCFC9Q33845967-C894FCF7-C2BD-4973-B6B0-DD7F3265C569Q34377823-44C2C53E-2902-48A1-8844-A56255ED176CQ34550700-0890486D-B478-4B2C-9260-21D76DD1F350Q34628842-E35ACD44-DF2A-469C-A0F9-C767D56C9E6AQ35669639-75EF1C4A-FB2A-47BF-AEA3-14A9856D6B71Q36080848-CAE4E8E7-F8A7-4119-8A46-462D467D023EQ36084452-4DA1255C-C871-4D41-A6CA-5C1BE6142D3BQ36256977-5DFF3CE6-4EF0-4506-8401-22A8D86D4580Q36491781-C5593288-F3AA-45D1-8FC9-618CFD2DDA17Q36619332-68806611-242A-471B-9266-F860D1C720F7Q36811051-1A77EFF0-DCF0-4E8D-837E-6958E06706EEQ36955650-14B59079-54E4-400D-935C-4CC9A307100DQ37132800-12C2F51A-45DA-4FCC-92C7-B842129959A2Q37225998-373B8745-EBCB-4709-9175-12768BF9CCCDQ37236636-72852A71-DDBA-44BF-80D4-F7D6B4813256Q37426039-1CC1B82C-9085-4A5E-B99C-1A6D4A632BC1Q37599805-CF176D56-0507-4B63-BB03-9A8C1A4A5F55Q38099178-74826F8E-9F79-4CFF-8A0B-45176212F5BDQ38301000-B04DE1D6-373E-4E39-B0D9-DC9B5F58D330Q38953024-CBFFEEF0-5794-4B16-9DBF-07F5066AE836Q39031683-0BC6B3AA-1772-4D9B-A8B9-4E053B1B15D4Q40333955-8E49F3F3-E334-4503-9C92-41B8C3743950Q40802058-DE63FBF6-E2A4-439A-8358-98C87A05E613Q41243981-38ACD7C5-4AD4-491A-8082-0649B5E478CAQ41605387-31D0AE3C-2879-4316-A870-FD5889143CA0Q42177413-045C619E-D1E1-439E-B619-36FC9E548C6CQ43119049-6DFA4690-C626-4F73-AE96-6DBA8C0A4640Q47972340-1191A897-0872-4432-80B5-17EBCF760994Q52590824-99B2250D-049E-4EE4-B7F4-859D8EA8B5CD
P2860
Cancer-associated carbohydrates identified by monoclonal antibodies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cancer-associated carbohydrates identified by monoclonal antibodies.
@en
Cancer-associated carbohydrates identified by monoclonal antibodies.
@nl
type
label
Cancer-associated carbohydrates identified by monoclonal antibodies.
@en
Cancer-associated carbohydrates identified by monoclonal antibodies.
@nl
prefLabel
Cancer-associated carbohydrates identified by monoclonal antibodies.
@en
Cancer-associated carbohydrates identified by monoclonal antibodies.
@nl
P1433
P1476
Cancer-associated carbohydrates identified by monoclonal antibodies.
@en
P2093
P304
P356
10.1016/0046-8177(90)90250-9
P407
P577
1990-10-01T00:00:00Z